NM_015214.3:c.94_101dupGATGCTGG
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_015214.3(DDHD2):c.94_101dupGATGCTGG(p.Ser35MetfsTer18) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_015214.3 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
The c.94_101dupGATGCTGG variant in the DDHD2 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The c.94_101dupGATGCTGG variant causes a frameshift starting with codon Serine 35, changes this amino acid to a Methionine residue, and creates a premature Stop codon at position 18 of the new reading frame, denoted p.Ser35MetfsX18. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The c.94_101dupGATGCTGG variant is not observed in large population cohorts (Lek et al., 2016). We interpret c.94_101dupGATGCTGG as a pathogenic variant. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at